In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study

被引：0
|
作者：
F Bonifazi
G Bandini
M Stanzani
F Palandri
B Giannini
M Arpinati
G Rosti
M Baccarani
机构：
[1] University of Bologna,Institute of Hematology ‘L. and A. Seràgnoli’
[2] S Orsola-Malpighi Hospital,undefined
来源：
Bone Marrow Transplantation | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1025 / 1026
页数：1
相关论文
共 50 条
  • [31] Phase II Clinical Trial Evaluating the Standardization of CD3+T-Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplants (PBSCT) from Matched Related Donors
    Bal, Susan
    Jamy, Omer
    Plews, Emily
    Bhatia, Ravi
    Lamb, Lawrence
    Bae, Sejong
    McKell, Amber T.
    Peavey, Daniel B.
    Kukkamalla, Rivvi
    Smith, Lauren C.
    Hill, Tiffany
    Salzman, Donna
    Innis-Shelton, Racquel
    Costa, Luciano J.
    Saad, Ayman
    di Stasi, Antonio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S178 - S178
  • [32] Peripheral blood stem cell RIC haploidentical transplantation low incidence of GVHD and non relapse mortality: Preliminary results from the prospective phase II UK Haplo study
    Raj, Kavita
    Protheroe, Rachel
    Smith, Matthew
    Gilleece, Maria
    Snowden, John. A.
    Uttenthal, Ben
    Irvine, David
    Collin, Matthew
    Paneesha, Shankaranarayana
    Salim, Rahuman
    Tholouli, Eleni
    Marwood, Ellice
    Mesiri, Pavlina
    Timur, Husne
    O'Connor, Charlotte
    Clifton-hadley, Laura
    Patrick, Pip
    Marks, David
    Mackinnon, Stephen
    Pagliuca, Antonio
    BONE MARROW TRANSPLANTATION, 2018, 53 : 752 - 754
  • [33] Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study
    Jiang, Jie-ling
    Gao, Wen-hui
    Wang, Li-ning
    Wan, Ming
    Wang, Ling
    Hu, Jiong
    FRONTIERS IN MEDICINE, 2021, 8
  • [34] Adult matched sibling blood cell transplants (BCT) after myeloablative conditioning incorporating daily intravenous (IV) Busulfan (BU) and low-dose antithymocyte globulin (ATG): Outcomes with particular respect to transplant-related mortality (TRM) in 140 patients.
    Russell, JA
    Chaudhy, AM
    Jeje, O
    Quinlan, D
    Stewart, D
    Morris, D
    Bahlis, NJ
    Savoie, L
    Brown, CB
    Larratt, L
    Geddes, M
    Turner, AR
    BLOOD, 2004, 104 (11) : 636A - 636A
  • [35] Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study
    Yang, Jun
    Jiang, Jieling
    Cai, Yu
    Li, Su
    Wan, Liping
    Zhu, Jun
    Liu, Huixia
    Shao, Shan
    Bai, Haitao
    Wang, Chun
    Song, Xianmin
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1049 - 1057
  • [36] Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study
    Jun Yang
    Jieling Jiang
    Yu Cai
    Su Li
    Liping Wan
    Jun Zhu
    Huixia Liu
    Shan Shao
    Haitao Bai
    Chun Wang
    Xianmin Song
    Bone Marrow Transplantation, 2019, 54 : 1049 - 1057
  • [37] Impact of low-dose irradiation and in vivo T-cell depletion on hematopoietic stem cell transplantation for non-malignant diseases using fludarabine-based reduced-intensity conditioning
    Umeda, Katsutsugu
    Yabe, Hiromasa
    Kato, Koji
    Imai, Kohsuke
    Kobayashi, Masao
    Takahashi, Yoshiyuki
    Yoshida, Nao
    Sato, Maho
    Sasahara, Yoji
    Kato, Keisuke
    Adachi, Souichi
    Koga, Yuhki
    Okada, Keiko
    Inoue, Masami
    Hashii, Yoshiko
    Atsuta, Yoshiko
    Morio, Tomohiro
    BONE MARROW TRANSPLANTATION, 2019, 54 (08) : 1227 - 1236
  • [38] Impact of low-dose irradiation and in vivo T-cell depletion on hematopoietic stem cell transplantation for non-malignant diseases using fludarabine-based reduced-intensity conditioning
    Katsutsugu Umeda
    Hiromasa Yabe
    Koji Kato
    Kohsuke Imai
    Masao Kobayashi
    Yoshiyuki Takahashi
    Nao Yoshida
    Maho Sato
    Yoji Sasahara
    Keisuke Kato
    Souichi Adachi
    Yuhki Koga
    Keiko Okada
    Masami Inoue
    Yoshiko Hashii
    Yoshiko Atsuta
    Tomohiro Morio
    Bone Marrow Transplantation, 2019, 54 : 1227 - 1236
  • [39] Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerism
    Bahceci, E
    Epperson, D
    Douek, DC
    Melenhorst, JJ
    Childs, RC
    Barrett, AJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (06) : 934 - 943
  • [40] Low-dose temozolomide modulation of peripheral blood regulatory T cells before dendritic cell-based vaccination in metastatic melanoma: Phase I/II study
    Ridolfi, L.
    Fiammenghi, L.
    Petrini, M.
    Granato, A.
    Ancarani, V.
    Pancisi, E.
    Guidoboni, M.
    Riccobon, A.
    Ascierto, P. A.
    Ridolfi, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345